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Used nuclear fuel has traditionally been treated through chemical separations of the 
radionuclides for recycle or disposal. This research considers a biological approach to such 
separations based on a series of complex and interdependent interactions that occur naturally in 
the human body with plutonium. These biological interactions are mediated by the proteins 
serum transferrin and the transferrin receptor. Transferrin to plutonium in vivo and can deposit 
plutonium into cells after interacting with the transferrin receptor protein at the cell surface.  
Using cerium as a non-radioactive surrogate for plutonium, it was found that cerium(IV) 
required multiple synergistic anions to bind in the N-lobe of the bilobal transferrin protein, 
creating a conformation of the cerium-loaded protein that would be unable to interact with the 
transferrin receptor protein to achieve a separation. The behavior of cerium binding to transferrin 
has contributed to understanding how plutonium(IV)-transferrin interacts in vivo and in 
biological separations.  
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Plutonium is an issue and a resource in used nuclear fuel because of its long half-life, 
high levels of radioactivity, and potential as a source of nuclear energy. Chemical schemes exist 
to partition plutonium and other components of used nuclear fuel for recycle or treatment. 
However, the existing chemical based separations are imperfect. Nature can already accomplish 
complex separations with different metals and thus provides the inspiration for an entirely 
different approach to separate radioactive metals, such as plutonium using networks of 
interacting biomolecules. This can increase the selectivity for the desired metal through 
sequential interactions that operate on length-scales larger than the metal-ligand bonds that drive 
chemical separations. 
An ever-present concern with all nuclear power plants is managing the radioactive 
byproducts, particularly the high level waste (HLW). The HLW from nuclear power plants 
accounts for only 1% of the volume of all radioactive waste generated, but it comprises 90% of 
the radioactivity of all generated waste (Hala and Navratil, 2003). That makes handling and 
disposing of HLW a primary concern because of its extreme radioactivity. HLW is principally 
used nuclear fuel, which has three major components: fission products, transuranic (TRU) 
actinides, and the initial constituents of the fuel elements that were not altered in the reactor 
(mostly unreacted uranium). Fission reactions of the heavy elements create new, lighter, 
elements (fission products) along with neutrons and energy. Neutron capture of the non-fissile 
uranium-238 in the fuel followed by successive beta decays predominantly form the transuranics. 
	 2 
Therefore, any nuclear power plant fueled with uranium will always have at least some 
transuranics in the used nuclear fuel.  
Nuclear power plants using low enriched uranium (LEU) have a characteristic 
concentration and distribution of fission products and transuranic actinides created in the fission 
reactions of uranium similar to that shown in Figure 1.1. Although, the proportion of elements in 
Figure 1.1 depends on the burnup of the fuel and can slightly differ between power plants, the 
differences are relatively small. 
       
Figure 1.1: Average composition of used nuclear fuel after one year of cooling for one ton of 
uranium that is 3.6% enriched with a 60 MWd/kg burnup. The uranium, which consists of 
approximately 95% of the mass of used nuclear fuel, along with other elements with little to no 
activity or mass are omitted for clarity (Choppin et al., 2013). 
 
 
When used nuclear fuel is removed from a reactor, it is initially stored in a cooling pond. 
Cooling ponds are primarily used for cooling the used nuclear fuel immediately after it is taken 
out of the reactor because the initial high levels of radiation produce a considerable thermal 
output and a substantial radiation field. Once the used nuclear fuel has had time to cool, it can be 





































left in the cooling ponds, disposed of, reprocessed, recycled, or some combination of the above. 
Currently, in the United States, used nuclear fuel is stored at the site of generation, indefinitely, 
pending the identification and selection of a suitable stable site for a geologic repository to bury 
the HLW.  
HLW needs to be isolated in geologic repositories because the activity levels of 
radioactive waste in untreated used nuclear fuel remain dangerous for hundreds of thousands to 
millions of years. The long-lived radionuclides produced in nuclear fuel would not only be stored 
for their half-lives but longer because it takes six half-lives for ~98.5% of a radionuclide to 




Figure 1.2: Activity over time for Np, Pu, Cm, and Am in used nuclear fuel after 33 MWd/kg 
burnup in a LEU reactor. The inflection points occur from the differing half-lives of the 
radioisotopes of the corresponding element. This figure has been modified from the original 
source (Choppin et al., 2013). 
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Further, the HLW’s radioactivity is compounded because radionuclides also have 
daughter products that are still radioactive and longer-lived. One way to mitigate the amount of 
radioactive material to be placed in long-term storage is to reprocess and recycle the used nuclear 
fuel in nuclear reactors designed to consume transuranics.  Reprocessing nuclear fuel for recycle 
requires separation of most of the fission products and the actinides. In addition to the 
radioactive fission products, used nuclear fuel contains significant quantities of fissile material 
other than the unreacted uranium, especially plutonium, which can also be used for nuclear 
power.  Unused fissile materials represent a valuable resource, so reprocessing to extract and 
recycle the plutonium is desirable. This thesis will specifically consider plutonium separations. 
Separating plutonium from irradiated fuel, or reprocessing, has been practiced since the 
1940’s. However, a major goal for advanced nuclear power systems is to take reprocessing to the 
next level using a two-pronged approach to selectively partition and transmute fissionable 
material in the used nuclear fuel. This approach has the advantage that most of the available 
energy can be used and less waste would need to be buried in geologic repositories. Partitioning 
and transmutation first separates the elements in the waste into groups that can either be disposed 
of together or recycled into fissionable fuel that can be consumed in a fast reactor. High energy 
neutrons in a fast reactor could transmute or break down most of the transuranic actinides and 
fission products that have half-lives of thousands to millions of years into either stable elements 
or radionuclides that have much shorter half-lives. The transmuted radionuclides could then be 
disposed in a geological waste repository for significantly less time than several thousand years. 
Current chemically based processes for used nuclear fuel separations use synthetic 
compounds to separate the used nuclear fuel by leveraging the variations in metal-ligand bond 
strengths. This process incurs a significant cost for the reuse of fissile material and the disposal 
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of used nuclear fuel’s byproducts. The basis of this thesis is to move beyond the metal-ligand 
bond as the primary distinguishing factor in separation by studying the interactions between a 
naturally occurring protein with the synthetic element, plutonium. Therefore, a method for 
plutonium separation and isolation can be explored using a natural process that separates metal 
ions using interactions other than simple metal-ligand bonds. 
1.1  Separations  
Effective and efficient separations can enable the strategy of removing and transmuting 
the long-lived radionuclides thus dramatically reducing the amount of HLW coming from 
nuclear power plants to a future waste repository. Currently several chemically based methods 
exist that are being considered for reprocessing HLW: such as Plutonium Uranium Redox 
Extraction (PUREX), Transuranium Extraction (TRUEX), TRAMEX and TALSPEAK. The 
chemical principles for these methods are well understood, however they still have some key 
limitations. This section presents an overview of these current separation methods and then 
discusses the details of using a different, biologically-based, approach to separations with a 
precise chain of interactions between proteins achieving the separation. 
1.1.1 Chemical Separations 
Ever since plutonium was discovered in 1941, plutonium has been recognized as a critical 
component for the nuclear fuel cycle because of plutonium’s potential as an energy source. That 
is the main reason why plutonium has been recycled and which was achieved by using chemical 
separation processes such as PUREX.  Presently, the PUREX process is the primary method for 
reprocessing and recycling the used nuclear fuel. This solvent extraction process mainly 
separates the uranium and plutonium from the other elements in the HLW using several steps. 
The used nuclear fuel is first dissolved in nitric acid and forms soluble uranium(VI) and 
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plutonium(IV) nitrates. A solution of diluted tri-n-butylphosphate (TBP) is then added to the 
dissolved fuel. TBP binds actinide nitrates in the hexavalent and tetravalent oxidation states 
(O’Boyle et al., 1997). Using TBP, the PUREX process initially separates the uranium and 
plutonium from everything else in the used nuclear fuel mixture. Next a reducing agent is 
introduced to reduce the plutonium to its trivalent state while leaving the uranium in the 
hexavalent state. Plutonium can then be separated and purified from the TBP solution since 
plutonium does not bind to TBP in its trivalent state. The last step continues with the removal of 
pure uranium from the TBP solution by treatment with very dilute nitric acid (Lamarsh and 
Baratta, 2001). The plutonium and uranium recovered and purified with the PUREX process can 
then be used as fuel in nuclear reactors. 
The other solvent extraction methods mentioned earlier, TRUEX, TRAMEX and 
TALSPEAK, were designed to separate specific actinides from the used nuclear fuel for 
reprocessing or disposal. These separation processes focus on the separation of the actinides 
from the lanthanides and fission products, or rather separating the long-lived radionuclides from 
the short-lived ones with nuclear properties that make them unsuitable for transmutation. By 
combining TBP with another solvent to extract a specific compound, an extractant, the TRUEX 
process can extract all the actinides in the trivalent, tetravalent, and hexavalent oxidation states 
from the HLW. The TRAMEX and TALSPEAK processes use high chloride concentrations or 
water-soluble aminopolycarboxylic acids, respectively, to separate the trivalent actinides and 
lanthanides (Schulz and Horwitz, 1986). While the separations are different for each process, a 
commonality between them all is that they leverage the thermodynamics and kinetics of the 
metal-ligand bond to accomplish the separations.  
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This strategy and current approach of reprocessing still presents some difficulties that 
stem from several factors. Recall from Figure 1.1 that the used nuclear fuel from LEU contains 
dozens of different elements but has a relatively consistent composition. Therefore, HLW will 
contain some elements that are chemically unique and others that can mimic the properties of 
other elements. In the PUREX process, the TBP can extract undesired fission products and 
actinides such as neptunium or technetium. The TRUEX, TRAMEX and TALSPEAK separation 
processes have similar problems because the thermodynamics and kinetics of the separation do 
not always allow full separation of pure actinides from the HLW. Those methods will extract 
most of the actinides from the lanthanides but they also can extract transition metals such as 
zirconium and palladium (Schulz and Horwitz, 1986). The transition metals are additionally 
extracted because of the similarities in the direct interactions of these metals with the extracting 
molecules. This inefficiency is a direct result of the metal-centered approach used to develop 
these reprocessing separation methods. There is an alternative approach for judicious chemical 
separation of used nuclear fuel that could allow its components with different chemical 
characteristics to be easily partitioned and treated differently or reused for other applications. A 
biologically based approach offers more ways for actinide separations than relying solely on a 
chemically based approach. 
1.1.2  Biological Separations 
Biological systems can already control the distribution of metals in living systems 
through an expansive sequence of interdependent interactions. Some of the proteins from 
biological systems, such as the transferrins, can be useful for separations because of their ability 
to transport specific metals via a series of interlocking steps and deliver those metals to the 
required locations at the right time. The various metal transport mechanisms of living systems 
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not only regulate the concentrations and distributions of natural, essential metals, but they can 
also remove some ‘non-essential’ metals that are toxic. ‘Non-essential’ metals are metals that are 
not required for cellular growth, such as gallium or hafnium (Harris and Pecoraro, 1983; Then et 
al., 1986). Understanding how some natural detoxifying biochemical processes operate could 
allow for the same approaches to separate specific elements in HLW using particular 
biomolecules. Work has been done to determine how non-essential metals in used nuclear fuel 
like thorium, neptunium, and plutonium bind to proteins in the transferrin family and are retained 
in the human body (Jeanson et al., 2010). The function and significance of the transferrins are 
elaborated in the next section. Particularly, this thesis will specifically expand on the work that 
has been done with plutonium and biomolecules.  
Plutonium is a major contributor to the toxicity and the difficulty of disposing of HLW. 
Following a biochemical approach for separating plutonium with biomolecules might be a more 
effective way to separate plutonium from used nuclear fuel. As mentioned earlier, solvent 
extraction methods of separations hinge on the relative thermodynamic strength of the 
interactions of metals with a manufactured ligand. Instead of using a synthetic material like TBP 
that is used to separate plutonium from used nuclear fuel by solvent extraction, one might exploit 
networks of naturally occurring biomolecules to separate plutonium. Such a biologically based 
approach could be based off the subtle, but very specific, interactions between the biomolecules 
and metal ions, just like the PUREX process. A biological approach will also include the natural 
network of interactions between the metal-biomolecule complexes and other biomolecules. The 
aforementioned network of interactions sets up a series of separation stages. This is due to the 
primary metal-binding biomolecules in nature often go on to interact in specific ways with other 
biomolecules as part of the specific recognition and uptake or rejection of metals. Not all 
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biomolecules can complete the necessary separation of the elements in used nuclear fuel; but 
possible candidates are being considered from the transferrin family of proteins because of their 
response to plutonium. 
1.2  Transferrins 
The transferrin family (transferrins) is a group of closely related proteins used by organisms 
for the transport and regulation of iron. Even though iron is essential for organisms to function, 
by itself iron can become toxic to organisms through iron-catalyzed formation of free radicals or 
precipitating as iron oxides that damage cells (Baker, 1994; Luck and Mason, 2012). Iron is also 
essential for bacteria to grow. Bacteria use another class of iron-binding compounds, 
siderophores to collect the iron they need from the surrounding environment (Neilands, 1995). 
Therefore, transferrins bind iron in the body both to prevent the generation of compounds that 
can deteriorate cells and to compete with the siderophores to keep bacteria from using the iron to 
grow. This project primarily focuses on one member of the transferrin family, serum transferrin. 
Serum transferrin (which is usually called transferrin) is principally used to move iron from the 
gut to individual cells in the blood. Another member of the transferrin family, lactoferrin, is 
present in milk, tears and saliva. Its primary function is to protect the body from infection by 
strongly binding free iron, denying it to bacteria.  
The overall purpose of the transferrins is to reversibly bind the free iron, keep the bacteria 
from using iron and deliver iron to the appropriate cells. Although transferrins are principally 
made to bind iron, they can bind to more than 30 different metals. The mechanism the 
transferrins use to bind and later release the iron and other metals is similar. However, each 
metal has its own binding affinities for transferrins. Some of the metal-binding studies that have 
been done with lactoferrin and transferrin are of particular interest because they examine what 
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can allow the difference in strength of the transferrins to bind each metal (Harris and Pecoraro, 
1983; Sharma and Singh, 1999). Due to their high affinity and ability to discriminate between 
different metal ions, transferrins could potentially be an ideal group of proteins to facilitate a 
biologically-based separation of metals. 
The metals that can bind to transferrin include elements essential for growth, non-
essential metals and even synthetic metals, such as plutonium (Jensen et al., 2011). It is 
remarkable that proteins such as the transferrins can identify and bind not only to naturally 
occurring non-essential elements, but also to synthetic elements such as plutonium. Moreover, as 
a metal transport protein, transferrin interacts with a larger network of biomolecules that can aid 
in the separation of particular metals.   
1.2.1  Interactions of the Metal Binding Site 
 
As referenced earlier, while the binding affinities of the transferrins are different for each 
of the metals, all of the transferrin family has the same basic structural components. All are 
bilobial, can bind two metals (one in each lobe), need a ‘synergistic anion’ in each lobe for 
strong metal binding, and can undergo significant changes in shape when metals bind to the 
protein. The two lobes, or halves, of the protein are called the N-lobe and C-lobe. Each lobe 
contains a high-affinity metal-binding site composed of one histidine (His), one aspartic acid 
(Asp) and two tyrosines (Tyr) (Pakdaman and El Hage Chahine, 1997). Although the metal 
binding residues in the N and C-lobes are the same, there are some functional differences 
between the two lobes. For instance, the C-lobe binds iron more strongly than the N-lobe, but the 
C-lobe also releases the iron faster than the N-lobe (Baker, 1994). 
A ‘synergistic anion’ is usually required in the binding site for a metal to bind strongly to 
the protein. For iron the synergistic anion under physiological conditions is carbonate, however 
	 11 
other anions such as oxalate, malonate, and nitrilotriacetate (NTA) can also function as 
synergistic anions (Schlabach and Bates, 1975). Figure 1.3 shows the N-lobe binding site in 
human serum transferrin with an iron(III) ion and a synergistic carbonate anion contained within 
the amino acid residues. This is a key aspect because iron binding is more than 1015 times weaker 
in the absence of a synergistic anion (Schlabach and Bates, 1975).  
 
 
Figure 1.3: N-lobe metal binding site of transferrin containing iron and a synergistic carbonate 
anion. The four amino acid groups (shown in blue) that directly bind to the metal (63-Asp, 95 
and 188-Tyr, 249-His) shown in light blue.  Shown in green (124-Arg, 120-Thr) are amino acid 
residues that interact with the synergistic anion. Oxygen atoms are indicated in red and nitrogen 
atoms are indicated in dark blue. Notice that the lobe is closed as all the amino acids are 
‘wrapping’ around the metal (Lambert et al., 2005). 
 
 
The metals generally bind to transferrin at the physiological pH ~7 (Lee and Goodfellow, 
1998). As the amino acid residues are deprotonated in a neutral to basic solution, they form polar 
bonds with the metal. The binding affinity for metals is different from metal to metal, as 
discussed later. The interaction of metals with the tyrosine groups in the metal binding site can 
cause large changes in the optical absorption spectrum of metal containing transferrins. For some 
metal transferrins, subtle changes in the optical spectra can also be observed if the identity of the 
synergistic anion changes. Therefore, optical spectroscopy is generally useful to monitor the 
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degree of metal binding in transferrins. The absorption spectra for metal binding to the 
transferrins have a typical trend, as shown in Figure 1.4 (Messori et al., 1999). 
 
Figure 1.4: UV difference spectra from progressive degrees of cerium(III) binding to lactoferrin. 
The increase in absorbance signifies an increase of metal binding to the protein. “Reprinted with 
permission from Smith, C., Ainscough, E., Baker, H., Brodie, A., & Baker, E. (1994). Specific 
Binding of Cerium by Human Lactoferrin Stimulates the Oxidation of Ce3+ to Ce4+. Journal of 




It is consistently observed that the absorbance peaks at ~240 nm and ~290 nm increase as 
metals binds to transferrins in the metal binding site. An absorbance peak near 242 nm is 
consistent with tyrosine ionization, which is essential for metal binding in the lobes (Gelb and 
Harris, 1980). Plutonium binding to transferrin causes the same increases in the absorption 
spectrum (Yule et al., 1992). The binding of amino acids to the metal not only cause changes in 
the UV spectrum but also changes the arrangement of the lobes and thereby the shape of the 
protein. The interaction between the synergistic anion and the protein also appears to influence 
the final conformation of the protein once the metal binds, in addition to stronger metal binding. 
When iron and carbonate bind in either the N-lobe or C-lobe of a transferrin, the lobes 
will close around the metal and the whole shape of the protein changes. This conformational 
change is characterized by the degree of lobe closure, which may be complete or partial and is 
dependent on the identity of the metal, the synergistic anion, and the lobe to which the metal-
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synergistic anion complex binds. A “correct” conformational change of the protein allows the 
protein to bind to the transferrin receptor protein on the cell surface. The metal-transferrin-
transferrin receptor protein complex can be carried into a cell through endocytosis where the 
metal can be released from the transferrin. An example of the correct conformation necessary for 
transferrin to interact with the transferrin receptor protein, complete lobe closure, is shown in 
Figure 1.5. 
  
Figure 1.5: Transferrin protein with both lobes closed around the iron (red) and carbonate 




An incorrect conformational change, i.e. partial (or no) lobe closure, will inhibit the 
metal-transferrin complex from efficiently binding to the transferrin receptor protein. Figure 1.6 
is an example of the transferrin with one of its lobes remaining open after metal binding. The 
interaction between the metal-transferrin complex and the transferrin receptor protein is a way 
that living cells distinguish between iron and other non-essential elements based on the shape of 
the metal-transferrin complex rather than the binding affinity of metals with transferrin, which is 
related to the strength of the metal-ligand bond. A transferrin complex containing bismuth and 
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iron is shown in Figure 1.6. In this protein, the N-lobe does not close around bismuth, which 
inhibits the transport of bismuth into cells, effectively separating bismuth from metals that cause 




Figure 1.6: Transferrin protein with iron (red) in the fully closed C–lobe and bismuth (gray) and 




Note that while the synergistic anion for iron is carbonate, the anion for bismuth is a 
larger and non-physiological anion, NTA. It is likely that the different sizes of the synergistic 
anions, along with metal, are causing the lobe to not fully close. The incomplete lobe closure that 
occurs with several metal-synergistic anion complexes of the transferrins (Yang et al., 2012; 
Baker, 1994) represents an opportunity to build a biologically-based separation. Like bismuth, 
plutonium is one of those metals that can cause one of transferrin’s lobes to not fully close 
because it has only been observed to bind in transferrin’s N-lobe with two synergistic anions, 
either one carbonate and one NTA or two carbonate ions. When plutonium and iron are in 
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transferrin’s N-lobe and C-lobe respectively, written as PuNFeCTf, or when plutonium binds in 
both lobes, PuNPuCTf, the N-lobe is not observed to close (Jensen et al., 2011).  
Although both of transferrin’s lobes bind plutonium strongly, only the C-lobe has been 
observed to undergo the correct conformational change when plutonium is present.  Transferrin 
only adopts the correct conformational change for a specific combination of iron and plutonium. 
Therefore, the complete, correct conformational change is only achieved for the protein when 
iron and carbonate are bound in the N-lobe and plutonium and its synergistic anions are bound in 
the C-lobe, FeNPuCTf.
 It has also been demonstrated that neither PuNFeCTf nor PuNPuCTf can 
effectively bind to the transferrin receptor protein, but FeNPuCTf binds to the transferrin receptor 
nearly as strong as FeNFeCTf, the receptor’s natural target and FeNPuCTf is taken up by cells 
unlike PuNFeCTf nor PuNPuCTf (Jensen, et al. 2011). 
1.2.2  Metal Release in Cells 
As mentioned earlier, transferrin can carry the iron (or other metals) into the cell after 
two molecules of serum transferrin binds to one transferrin receptor protein to create a metal-
protein-transferrin receptor complex, as shown in Figure 1.7.  
 
Figure 1.7: Transferrin Receptor Protein with Transferrins: image constructed from PDB ID: 
1SUV using VMD. The two transferrins (green and tan) are bound to the transferrin receptor 




Recall that only the closed conformation of serum transferrin can bind to the transferrin 
receptor protein, which then takes the two serum transferrins into a cell. The release of iron into 
the cell is another critical step in the biological process to consider. One of the mechanisms that 
cause the metal to be detached from transferrin is the increased acidity of the pH inside the cell’s 
endosomes (Baker, 1994; Gelb and Harris, 1980). Lowering the pH of the solution will 
effectively reverse the metal binding process by allowing the amino acid residues near the 
binding site to be protonated thereby letting the metal go into solution in the cell or potentially to 
be extracted in a waste separation. As mentioned earlier without a synergistic anion to help hold 
the metal in the binding site, the amino acids weakly bind to the metal. Figure 1.8 illustrates the 
impact that the pH can have on the metals, iron and cerium, binding to the transferrins while in 
solution. The pH is also important because the conformation of the protein changes from a closed 
to an open configuration when the metal is released. 
 
Figure 1.8: Release of iron carbonate from transferrin (Fe-Tf) and lactoferrin (Fe-Lf) and the 
release of cerium carbonate from lactoferrin (Ce-Lf) over the pH range 2-8. “Reprinted with 
permission from Smith, C., Ainscough, E., Baker, H., Brodie, A., & Baker, E. (1994). Specific 
Binding of Cerium by Human Lactoferrin Stimulates the Oxidation of Ce3+ to Ce4+. Journal of 




1.3  Hypothesis 
A biologically based separation for plutonium using transferrin requires the interactions 
summarized above. The plutonium binds with a specific synergistic anion creating a complex 
that is strongly held in each of transferrin’s lobes. The initial, underlying hypothesis of this work 
is that the synergistic anion(s) is the major determining factor in achieving the correct 
conformation of plutonium-transferrin, and that the N-lobe will close when one plutonium ion 
and one carbonate bind there, just like it does for iron. Starting with the trivalent state of 
plutonium will increase the solubility at the protein-compatible pH values, which should give 
greater control over the nature and number of synergistic anions in the N-lobe’s active metal 
binding site. Transferrin would then undergo a conformational change that should allow it to 
bind to the transferrin receptor protein to form a plutonium-protein-transferrin receptor protein 
complex that could be separated by this biological pathway.  
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This chapter focuses on the materials and methods used to make and verify the cerium-
transferrin complexes. The first section, Section 2.1, contains chemicals that were used 
throughout multiple experiments. The following section, Section 2.2 describes the buffers and 
specific solutions that were made. Section 2.3 goes into specific instruments that were used for 
analysis. Section 2.4 describes the various methods used for preparing the protein, making metal-
protein complexes, assaying the unbound and bound metals, and tools for data analysis. 
2.1  Reagents 
The following chemicals were bought from Sigma-Aldrich and used as received: L-
ascorbic acid (C6H8O6, , ≥ 99.0%, BioXtra), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES, minimum 99.5% titration), ammonium cerium (IV) nitrate ((NH4)2Ce(NO3)6 ≥ 99.99% 
trace metal basis), iron(III) chloride hexahydrate (FeCl3•6H2O, reagent grade, ≥ 98%, purified 
lumps), sodium carbonate-13C (Na2
13CO3, 99 atom% 
13C), 2-(N-morpholino)ethanesulfonic acid 
(MES solution, cell culture grade), Sephadex G-100 (superfine), apo-transferrin (bovine, ≥ 98%, 
referred to as Tf), hydrogen peroxide (H2O2, 30%, TraceSELECT Ultra) and 
tris(hydroxymethyl)aminomethane (Tris, ≥ 99.9%). Transferrin without any metal bound in the 
N and C-lobe is referred to as apotransferrin. Note that for simplicity in all subsequent references 
bovine serum transferrin is referred to as Tf. 
The following chemicals were bought and used as received from other suppliers. The 
chemicals from Macron: sodium chloride (NaCl, ≥ 99.0%), sodium bicarbonate (NaHCO3, 99-
100.5%), hydrochloric acid (HCl, 36.5-38%). Arsenazo III was purchased from Fluka. The 
chemicals from Alfa Aesar: cerium(III) chloride heptahydrate (CeCl3•7H2O, 99%) and sodium 
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formate (99.0% min). The chemical from Fisher: sodium hydroxide (NaOH 50% w/w). A cerium 
stock solution of Ce(NO3)3 previously prepared and standardized was diluted and used as 
needed. The lanthanides ytterbium(III) nitrate, samarium(III) nitrate and neodymium(III) nitrate 
were also used from stock solutions that were standardized with ICP-OES. All cerium stock 
solutions were kept between pH 1.0-3.0 to prevent hydrolysis or precipitation of the cerium. 
Otherwise at a higher pH, insoluble cerium(IV) hydroxides will form and precipitate unless the 
metal ions are bound to a chelating agent like NTA prior to binding to transferrin (Yu et al., 
2006; O’Boyle et al., 1997). All aqueous solutions used 18 MΩ water. 
2.2  Solutions 
2.2.1  Buffer Solutions 
Two types of buffer solutions (HEPES and Tris) were used for protein storage and 
experimentation. Both buffer solutions contained 0.1 M NaCl and depending on the experiment, 
NaHCO3. Unless otherwise noted, the HEPES buffer solution was kept at either pH 7.5 ± 0.1 and 
the Tris was kept at pH 8.0 ± 0.1. The sodium perchlorate buffer consisted of 0.134 M EDTA 
(EDTA disodium salt), 0.1 M HEPES, and 2.67 M sodium perchlorate (NaClO4, 98%) at pH 7.4.  
2.2.2  Strip Solution for Cerium 
A strip solution was used for efficient removal of cerium from the protein’s lobes and 
reduces cerium(IV) to allow for spectrophotometric analysis of the cerium concentration. The 
strip solution consisted of 0.1 M sodium acetate and 0.1 M ascorbic acid at pH 4 ± 0.1. This 
solution was made fresh daily because the ascorbic acid degrades over time. Cerium was stripped 
from transferrin by adding 1:4 volume ratio of strip solution: buffer solution to the protein 
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solutions. The metal is stripped instantly and reduced rapidly as verified visually by as the 
reddish colored solution turns colorless or specifically by UV-Vis spectroscopy. 
2.2.3  Iron(NTA)2  
 Since the transferrins readily bind iron, the Fe(NTA)2 solution was used as a control and 
comparison for cerium binding to transferrin. Fe(NTA)2 solutions were prepared fresh daily 
when used. The starting materials used were: ~10 mM FeCl3•6H2O, ~20 mM NTA, HCl, and 
NaOH. This solution was prepared by scraping off the outer layer of the FeCl3•6H2O lumps and 
using the FeCl3•6H2O layer underneath. The weighed mass of FeCl3•6H2O was initially 
dissolved in 1.2 M HCl and diluted with water in a volumetric flask. Exactly two equivalents of 
NTA were added from a 200 mM NTA stock solution at pH 7.35 ± 0.1. The solution was then 
diluted to the mark to make ~10 mM Fe(NTA)2. The resulting solution was stirred vigorously 
without splashing, as 1 M NaOH was slowly added dropwise to bring the solution to pH 4.5 ± 
0.1. An iron-hydroxide precipitate will form if the solution is not rapidly stirred or the base is too 
concentrated or added too rapidly. 
2.2.4  Other Cerium Solutions 
Additional solutions of cerium were made from (NH4)2Ce(NO3)6 in the presence of NTA 
or cerium(III) chloride. Sufficient ceric ammonium nitrate was weighed out to prepare a ~20 mM 
solution of Ce(IV). It was dissolved in a NTA solution of 50 mM NTA, 20 mM Tris and 100 
mM NaCl at pH 6 after extended mixing. Cerium(III) was weighed out to prepare a 0.01 M 
cerium(III) solution. Using a volumetric flask, cerium(III) was dissolved in water and adjusted to 
pH 4 using dilute concentrations of HCl, water was then filled to the line and pH checked to be at 
4 ± 0.1. 
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2.3  Equipment 
2.3.1  Spectral Analysis  
A Cary 300 dual beam spectrophotometer was used for all spectrometric analysis at a 
scan rate of 300 nm/min. Background subtracted spectra were collected against a solvent/buffer 
reference. Difference spectra were collected with protein-containing buffers in the reference, 
unless otherwise noted. Quartz cuvettes (1.000 cm path length) were always used to determine 
protein concentration or for protein analysis. Disposable plastic cuvettes (1.00 cm path length) 
were used for the Arsenazo III assay procedure described below. This is because the plastic 
cuvettes cannot be reliably used for absorbance measurements below 350 nm. 
2.3.2  pH Adjustment  
The pH was adjusted using a Thermo Scientific pH meter with an Orion 8220BNWP 
PerpHecT pH Ross Combination Microelectrode. The pH electrode was filled with 3 M NaCl 
and stored in the same solution. It was calibrated before each use with pH 4.00 and 7.00 buffer 
solutions from Fisher Scientific. Adjustment of the pH of the solutions was done using HCl and 
NaOH.  
2.4  Methods 
2.4.1  Protein Purification  
The proteins were always purified by size-exclusion chromatography before use to 
remove any damaged protein, impurities, and residual buffers. This was done by dissolving ~60 
mg of bovine transferrin in 3 mL of buffer solution. The buffer solution contained 0.1 M sodium 
chloride and either 10 mM HEPES or Tris at pH 7.5 or 8.0, respectively. The resulting transferrin 
solution was passed through the Sephadex column. The Sephadex column was prepared by 
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heating ~3.2 g of Sephadex G-100 beads at 32 °C in a water bath for three hours and then poured 
into a glass column to be packed and rinsed with the buffer solution. The bed volume for the 
beads was ~ 42 cm3, with a free column volume of ~25 mL. The transferrin buffer solution was 
loaded onto column as the last of the rinse buffer (same buffer solution as used with the 
transferrin) sunk into the bead bed. As soon as all 3 mL of the transferrin buffer solution sunk 
into the column bed, the column was carefully loaded with the same buffer solution to elute the 
protein through the column. The solution was eluted in 3 mL fractions at four to five drops per 
minute using a Bio-rad model 2110 fraction collector. 
The protein concentration of the fractions was determined from their UV spectra using 
the molar extinction coefficient for apotransferrin of 93,000 M-1cm-1 at 280 nm (Bali and Harris, 
1990). The three fractions with the highest transferrin content were combined and concentrated, 
including the diluted fractions that were used to measure the spectra. All other fractions usually 
contained less than 10 µM Tf and were discarded as either having impurities or protein 
degradation. Typically, ~55 mg of protein was recovered. The result of one of the protein 
purifications is shown in Figure 2.1. 
 
Figure 2.1: Protein purification in fractions (vials), the calculated absorbance from the 
spectrophotometer was used to ascertain the initial concentrations of the vials that were diluted 
so that the protein concentration can be accurately measured. 














Since the protein purification process dilutes the protein to ~30 µM protein, the protein 
solution was concentrated from 350 to 650 µM by centrifugation in Amicon Ultra centrifugal 
filter devices with a 10 kDa molecular weight cutoff. All protein solutions from purifications and 
experiments were centrifuged at 4oC with either the 5415 R Eppendorf or the Biofuge 22 R 
Heraeus centrifuges. The former was used for solutions that were < 500 µL and the latter for 
solutions > 500 µL. 
2.4.2  Making Cerium(III)-Tf Complexes  
Cerium(III)-transferrin complexes were prepared by combining known amounts of the 
cerium nitrate solution and transferrin. The concentration of protein in solution was determined 
analytically using the spectrophotometer, and typically ranged from 10 - 25 µM in 1 mL buffer 
solution. Higher concentrations were generally not used because of the high molar absorptivity 
of the absorbance peak at 280 nm (93,000 M-1cm-1 for apo-Tf). Once the exact concentration of 
protein was known, the desired molar equivalents of cerium(III) were added to the protein 
solution and the change in the absorption spectrum was measured after each addition of metal. 
For UV difference spectroscopy, the protein was also added to the reference cuvette and diluted 
with the same volume of buffer solution as the cerium(III) solution in the sample. The pH buffer 
present in solution was able to keep the solution at pH 7.5 or 8.0 ± 0.15 as long as the total 
volume of the metal additions was < 50 µL. After sufficient incubation time, the final solutions 
were analyzed to determine the ratio of bound and unbound cerium as described below. 
2.4.3  Arsenazo III Assay Procedure 
The concentration of unbound and bound cerium in the transferrin solution was 
determined spectrophotometrically using Arsenazo III. First, unbound cerium had to be separated 
from the transferrin-bound cerium. Solutions containing cerium and transferrin at known total 
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concentrations and volumes were centrifuged through a 10 kDa Millipore Amicon filter. 
Transferrin has a molecular weight of 77 kDa, so the filter retains the protein and consequently 
anything that is bound to the protein, while unbound cerium passes through in the filtrate. The 
first filtrate, which contains unbound cerium at the same concentration as the original solution, 
was set aside and then the protein in the filter was rinsed several times with buffer to remove any 
residual unbound metal. The strip solution was then added to strip the cerium from the protein 
and the resulting solution was diluted to a known volume. The sum of the moles of unbound and 
bound cerium would equal to the initial amount of cerium(III) placed in the solution.  
The second step for determining the amount of unbound and bound cerium was to assay 
the separated cerium using spectrophotometry of the cerium-arsenazo III complex (Marczenko, 
1976). If iron was expected to be present in the solution, an additional 400 µL ascorbic acid was 
added, to reduce iron to iron(II) and keep it from reacting with aresenazo III; the ascorbic acid is 
not needed if there is no iron in solution. A calibration curve, which gave a linear response 
between 2 and 10 µM Ce, as shown in Figures 2.2 and 2.3. The peak at 650 nm increases when 
there is more metal in solution. 
 
Figure 2.2: Spectra of 0, 2, 4, 6, 8, and 10 µM cerium – Arsenazo III solutions. The 

















Figure 2.3: Calibration curve for cerium using the 650 nm absorbance peak with the 
blank subtracted (0 µM [Ce]) vs. the metal concentration (y=0.05246-0.03729, 
R2=0.98193). 
 
2.4.4  Making Cerium(IV)-Tf Complexes  
Two methods were used to prepare cerium(IV)-transferrin complexes. The first method 
used 5 µL of 5% hydrogen peroxide to a 1 mL cerium(III)-transferrin solution. This has been 
previously used to rapidly oxidize the cerium in lactoferrin (Smith et al, 1994). The second 
method is to rinse the cerium-protein-buffer solution 3-4 times with freshly made 5 mM CO3
2- 
buffer solution and allow oxygen in the solution to oxidize the cerium(III)-transferrin. The 5 mM 
CO3
2- buffer solution was made by adding NaHCO3 to degassed buffer solution. The degassing 
process is to remove any previous carbonate existing in solution (ambient CO3
2-). Any 
evaporated water from the degassing process was added back from concurrently degassed water 
to ensure the buffer concentration stayed the same. Right after the cerium(III) is added to the 
CO3
2- buffer solution, the cerium(III)-transferrin is sealed with parafilm, and stored at ~4 °C for 
a fortnight (Smith et al, 1994).  


















2.4.5  Making Cerium and Iron-Tf Complexes  
Determining the selectivity of cerium binding to either the C or N-lobe was done by 
making both FeNCeCTf and FeCCeNTf complexes. These are otherwise referred to as mixed 
metal-protein complexes and can be made by first manipulating iron into the desired lobe and 
then loading the cerium in the vacant lobe.  
FeCCeNTf complexes were made using the following materials and solutions: Fe(NTA)2, 
transferrin, MES buffer, HEPES solution, and the final desired buffer solution. The MES buffer 
consisted of 0.05 M NaCl, 0.005 M CO3
2-, and 0.01 M MES at pH 5.00 ± 0.02. Purified 
apotransferrin in HEPES or TRIS buffer solution was rinsed 4-5 times in MES buffer and 
warmed to 37 oC in a water bath. After the protein concentration was confirmed using the 
spectrophotometer, one mole of Fe(NTA)2 per mole of Tf was added. The protein solution 
instantly turned red when the iron was added. The solution was incubated at 37 °C for 1 hour and 
the absorption spectrum was measured between 650-240 nm to verify the degree of iron loading. 
An equal volume of an HEPES buffer solution (0.01 M HEPES and 0.00589 M NaOH) that had 
been warmed to 37 °C was added to the transferrin solution. The solution was incubated for 
another hour at 37 °C and the spectrum was measured over the same wavelength range. After 
rinsing the protein solution 4-5 times with the desired final buffer solution to remove excess 
NTA, the solution was diluted to the desired protein concentration and cerium(III) was added to 
form FeCCeNTf after air oxidation. All rinses were done with at least a 1:4 volume ratio of initial 
solution: desired buffer solution. 
FeNCeCTf complexes were made using the following materials: Fe(NTA)2, transferrin, 
sodium perchlorate buffer, HEPES buffer, and the final desired buffer solution. After the protein 
concentration was confirmed spectrophotometrically, a 2.2:1 molar ratio of iron(III): transferrin 
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was added using the Fe(NTA)2 solution. The iron-transferrin solution was incubated at 4 °C 
overnight to obtain Fe2Tf. The excess iron and NTA were removed by repeated washing. A 50 
mM HEPES buffer containing no added salt at pH 7.4 was prepared and stored at 4 °C overnight. 
On the following day, the iron-transferrin solution was washed to remove excess iron and NTA 
using a 10 kDa centrifugal filter and concentrated to 300 µL. The Fe2Tf solution and the sodium 
perchlorate buffer were warmed to 37 °C in a water bath, and then mixed in a 1:3 ratio (300 µL 
of Fe2Tf and 900 µL of sodium perchlorate buffer). The resulting solution was incubated for 30 
minutes at 37 °C. The spectrum from 650-240 nm was measured immediately after mixing and 
again after 30 minutes. The absorbance at 460 nm from the iron-transferrin complex should have 
decreased by approximately half during the incubation. After the spectrum was measured, the 
reaction was immediately quenched by diluting the protein-perchlorate solution with 10 volumes 
of cold 50 mM HEPES buffer solution. The solution was immediate centrifuged through a 10 
kDa centrifugal filter to remove the EDTA and perchlorate. The cycle of washing with cold 50 
mM HEPES solution and centrifugation was repeated until the residual EDTA and perchlorate 
concentrations were less than 1 pM each.  The resulting solution of FeNTf was diluted in the 
desired buffer to the desired protein concentration and cerium(III) was added to form FeNCeCTf 
after air oxidation. 
2.4.6  NMR Procedure  
Nuclear magnetic resonance (NMR) was used to determine the amount of cerium-
carbonate bound in each lobe of transferrin. The protein concentration for NMR analysis should 
be at least ~1 mM Tf otherwise the peaks will be difficult to discern from the noise level. The 
cerium(IV)-transferrin complex was made with the 5 mM CO3
2- method described in Section 
2.4.4 at a concentration of ~50 µM Tf. However, the carbonate used in this solution was sodium 
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carbonate-13C, 99 atom %, and the total solution volume was 25 mL. The solution is then spun 
down to ~ 1 mL after allowing at least a fortnight for air oxidation of the cerium(III). A freshly 
made ‘D2O solution’ was used as the solvent for the NMR, that consisted of 50/50 of deuterium 
oxide (D2O) and 18 MW H2O solution, with the same concentrations of buffer, salt, and 
carbonate (sodium carbonate-13C) used previously in the buffer solution at pH 8. The Ce2Tf 
solution was rinsed 4-5 times at a 1:5 ratio of buffer solution: D2O solution. Over the course of 
the buffer exchange and the NMR measurement, any exchange between carbonate from the 
atmosphere and 13C in solution is less than estimated experimental uncertainty of 10%. The 13C 
labeled Ce2Tf solution was placed in a cap sealed NMR tube. The spectrum was recorded using a 
JEOL 500 MHz liquid state NMR with a resonance frequency 125 MHz for a 13C NMR spectra 
with 20,000 scans (~16 hours). 
2.4.7  SAXS Solutions and Analysis 
Small Angle X-ray Scattering (SAXS) measurements were made using beamline 12-ID-B 
at the Argonne National Laboratory Advanced Photon Source. Scattering of the protein solutions 
was measured in a capillary flow cell at an incident energy of 14 keV. This beamline setup gave 
a maximum Q-range of 0.003 – 1 Å-1. Multiple samples were prepared and analyzed including: 
cerium(IV) prepared by oxidizing cerium(III) with hydrogen peroxide (Ce4+Tf_H2O2), 
cerium(IV) prepared using NTA ((Ce
4+)2Tf_NTA), iron(III) with transferrin ((Fe
3+)2Tf), 
cerium(IV) prepared with air oxidation in 5 mM carbonate (Ce4+Tf_Carbonate), and 
apotransferrin. For comparison and analysis, multiple concentrations of transferrin were used: 
0.5, 1.0, 2.0, 5.0, 10.0, and 20.0 mg/mL. The solutions were prepared using the procedures 
mentioned earlier.  
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The scattering intensity of each set of solutions was background subtracted using the 
experimentally determined scattering pattern of a corresponding buffer solution. The buffer 
solution was scanned after every 3-4 measurements of a protein-containing sample. The 
scattering intensity of each sample (including the buffer) was the average of 20 scans (1 second 
acquisition time per scan with a 2 second delay between scans). Between samples, the flow cell 
was extensively washed to remove any residual metal or protein from the previous sample. For 
example, solutions of 0.5, 1.0, 2.0, 5.0 and 10.0 mg/mL Tf bound to cerium(IV) and treated with 
hydrogen peroxide were measured. The corresponding buffer was Tris at pH 8.0. The order for 
the scans would be: buffer, 0.5, 1.0 buffer, 2.0, 5.0 buffer, 10.0, and rinse.  
The averaged scattering data were processed using Igor Pro to subtract the background 
from the sample spectra and save the corrected data between Q = 0.017 and 0.7 Å-1.  The data 
was then further processed using GNOM, DAMAVER and DATGOM from the ATSAS 
software suite (Svergun, 1992; Volkov and Svergun, 2003; Petoukhov et al., 2007) to compute 
the most probable shape of the protein.  The maximum distance across the protein, Dmax, was 
estimated using DATGNOM and manually, using GNOM with 5 Å increments around the 
expected value of Dmax. The structures of each of the samples with differing Dmax values were 
compared for consistency and to discern which Dmax value and concentration of protein gave the 
best fit for the sample as well as the set. The resulting protein models were transformed for 
visualization using the program Situs and displayed using Visual Molecular Dynamics (VMD). 
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CERIUM BINDING WITH TRANSERRIN 
 
 
Plutonium, like all actinides, is dangerous to work with because of its radioactivity and 
toxicity. Therefore, non-radioactive chemical surrogates are sometimes used in actinide research. 
The surrogates are significantly safer and cheaper to use and dispose of than the actinides they 
replace. Depending on the chemistry involved, there are several different elements used as 
surrogates for plutonium. Key considerations while selecting a surrogate to study transferrin 
binding include the ionic size, electronic structure, chemical characteristics, and the ability of the 
surrogate to be oxidized from the trivalent to tetravalent oxidation states.  
The lanthanide element cerium has shares all these characteristics with plutonium when 
bound to the transferrins and has previously been identified as a possible surrogate for plutonium 
(Smith et al., 1994; Jensen et al., 2011). Cerium has been identified as a surrogate for plutonium 
in other studies such as in electrorefining and fire conditions possibly formed in the PUREX 
process (Raraz et al., 1992; Šulka et al., 2014). These two processes note similar characteristics 
and behavior of cerium and plutonium for their respective applications. As previously seen, the 
optical spectrum of cerium(IV)-transferrins is particularly sensitive to metal and synergistic 
anions binding. The much lower toxicity and non-radioactivity of the naturally occurring 
isotopes of cerium and its innate characteristics make it an ideal surrogate for plutonium in this 
work. This chapter first summarizes the current understanding of how plutonium interacts with 
transferrin and then discusses the results of experiments studying the interactions of cerium with 
transferrin.  
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3.1  Plutonium in the N-lobe 
Recall that the long-term goal of this work is to develop highly selective separations of 
the actinides, particularly plutonium, using networks of biomolecule interactions. The 
conformational change of the transferrins that occurs with plutonium binding and the interaction 
of fully closed metal-transferrins with the transferrin receptor protein conceptually could be 
exploited in a biochemical separation process of actinides. To achieve this, it needs to be 
understood why the N-lobe has not been observed to fully close when plutonium or cerium bind, 
even though those metals can cause the C-lobe to close. Understanding this will enable control of 
the separation of plutonium by controlling the conformation of the metal-transferrin complex. 
The previous work on metal-transferrins suggests that the final conformation of the transferrin is 
likely governed by both the metal and the synergistic anion (Baker, 1994). As mentioned earlier, 
plutonium can bind to transferrin and adopt the correct conformation with FeNPuCTf when NTA 
is the synergistic anion for the plutonium and carbonate is the synergistic anion for iron (Jensen 
et al., 2011). The next step in using transferrin and the transferrin receptor protein to separate 
plutonium is to induce a pure plutonium-transferrin, PuNPuCTf, to adopt the correct, fully closed 
conformation that will allow it to strongly bind to the transferrin receptor protein. Therefore, 
understanding why the N-lobe stays open or becomes closed could allow for the protein 
transferrin, which principally transports iron, to be used to make a two-staged separation of 
plutonium. 
The goal is to understand how plutonium and the synergistic anion affect the N-lobe’s 
closure in transferrin. A possible configuration for the plutonium to bind in the N-lobe and obtain 
full lobe closure is given in Figure 3.1. Notice that the amino acid residues and one carbonate are 
able to fully surround the metal. 
	 36 
 
Figure 3.1: Possible configuration of transferrin bound to plutonium(IV) 
 
 
The belief is that having two or more synergistic anions bound to the metal as it binds to 
the metal binding site of the lobe affects the degree of lobe closure. The cause keeping the N-
lobe from fully closing could be the physical size of the synergistic anion(s) or a different set of 
interactions with the amino acid residues, for example the presence of two or more synergistic 
anions may block an amino acid residue from binding to the metal. Recall that different 
synergistic anions can assist the metal binding to the protein but carbonate is smaller than most 
known synergistic anions, including NTA (Schlabach and Bates, 1975). The hypothesis is that 
one plutonium and one carbonate bound in the N-lobe will allow the N-lobe to fully close. 
3.1.1  Cerium, a substitute for plutonium 
Using a plutonium surrogate, cerium, for experimentation will help us achieve the goal of 
being able to isolate and separate plutonium using the protein, transferrin. The oxidation state of 
plutonium when it is bound to transferrin is 4+ (Jensen et al., 2011). For cerium transferrin’s 
behavior to be an accurate representation of plutonium transferrin, cerium also needs to be 
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present as cerium(IV) after it has bound to the transferrin, in both lobes. Hafnium and 
praseodymium were also considered for experimentation. While hafnium mimics several of 
plutonium’s biological characteristics (Then et al., 1986), and it binds to transferrin as 
hafnium(IV), it does not exist as Hf3+ in solution, therefore it will not mimic plutonium’s redox 
chemistry. Like cerium, the electronic structural size of praseodymium is close to plutonium but 
it is considerably more difficult to oxidize praseodymium from 3+ to 4+ and praseodymium(IV) 
will not persist when bound to transferrin. As a comparison and test for cerium binding to 
transferrin, several heavier lanthanides were briefly used: neodymium, samarium, and ytterbium. 
3.2  Cerium-Transferrin Complexes  
Unfortunately keeping significant concentrations of either element (plutonium or cerium) 
soluble in the 4+ oxidation state until they can bind to transferrin is difficult because the 
transferrin solution needs to be close to physiological conditions, which requires near neutral pH. 
Keeping the metal-ion solution acidic (less than pH 5) does keep the metal from hydrolyzing and 
in the 3+ state in solution but that is too acidic for cerium to bind transferrin (Smith et al., 1994). 
Ligands, such as NTA, can keep tetravalent actinide or lanthanide ions in solution at a higher pH 
but the use of NTA needs to be avoided because NTA can act as a co-synergistic anion along 
with carbonate so the metal and two synergistic anions bind in the N-lobe. Previous plutonium or 
cerium transferrin complexes have only been made with NTA and another synergistic anion in 
the N-lobe. Fortunately, a previous study using cerium and the closely related protein lactoferrin 
serves as a guideline (Smith et al., 1994) to binding cerium to transferrin without NTA or similar 
synergistic ligands. Recall that lactoferrin is directly related to transferrin in its ability to bind to 
iron and other metals with synergistic carbonate ions and it undergoes the same conformational 
changes, but it does not interact with the transferrin receptor proteins as transferrin does. Unlike 
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the tetravalent oxidation state, the trivalent ions of cerium and plutonium have some, short-term 
solubility near pH 7, before they transform into insoluble metal oxides. This should allow the 
metals to be soluble in the absence of NTA and then bind to the transferrin along with a single 
synergistic anion, carbonate.  
This work to bind cerium to transferrin with only one synergistic anion in each lobe 
includes two major phases. The first step is to use more soluble cerium(III) in the presence of 
carbonate to create transferrin with cerium(III) bound in the N and C-lobe of transferrin, 
represented as (Ce3+)2Tf. The second step is to then oxidize the cerium while the metal is in both 
lobes, to make (Ce4+)2Tf. The original experimental objective of making (Ce
4+)2Tf is so that the 
binding of trivalent actinides or lanthanide carbonates to transferrin can be tested and then to 
help develop a workable oxidation process. Also, and importantly, to readily check that (Ce4+)2Tf 
has the correct conformation when one carbonate is attached to each metal. If successful this 
approach would then be applied to plutonium. 
3.3  Verification of Cerium-Transferrin Complexes  
 Before making the (Ce3+)2Tf and (Ce
4+)2Tf complexes using carbonate as the synergistic 
anion, (Ce4+)2Tf complexes were made by using NTA as the synergistic anion as a control, 
which will be referred to as (Ce4+)2Tf_NTA. The NTA can be replaced as the synergistic anion 
with carbonate by washing out the NTA with a buffer solution containing a high concentration of 
carbonate, ~0.1 M. It is already known that (Ce4+)2Tf_NTA has an open N-lobe even with the 
NTA replaced with carbonate, which forms a complex with two carbonates in the N-lobe, which 
takes several minutes, but (Ce4+)2Tf_NTA represents an effective control for making the cerium-
transferrin complexes with only carbonate. 
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3.3.1  Lanthanide(III)-Transferrin Complexes  
Recall that the metal-transferrin spectra in Figure 1.4 had peaks at ~240 and ~290 nm that 
were increasing as cerium(III) was added to a lactoferrin solution. Depending if metal has bound 
or remained unbound in the N or C-lobe causes changes in the spectrum for transferrin. Using a 
HEPES buffer solution with ambient carbonate, Figure 3.2 shows that only the peak at ~240 nm 
is increasing as cerium(III) is being added to transferrin. This discrepancy in increasing peaks 
therefore suggests that significantly less metal binding, if at all, is occurring for the transferrin 
solution. The consistent rise of the spectra from 450-300 nm over each addition also reinforces 
the assumption that metal is mostly present in solution, i.e. not binding to the transferrin.  
 
Figure 3.2: UV-Vis difference spectra of the incremental additions of 0.5 equivalents Ce3+ to a 
buffer solution of ~5 µM Tf up to a 4:1 molar ratio of cerium: transferrin was achieved. The 
other equivalents are omitted for clarity. 
 
Cerium assay analysis confirmed that only a 1:1 molar ratio of cerium(III): transferrin 
was initially achieved.  Although experiments have been done using cerium(III) and lactoferrin, 
the binding ability of cerium(III) for transferrin was unknown. To understand if the initially 
observed 1:1 molar ratio of cerium: transferrin complex was a limiting species by studying the 




















transferrin complexation of smaller lanthanide(III) ions. The transferrin was then tested by 
binding some of the heavier lanthanides to transferrin using the HEPES buffer solution with 
ambient carbonate. Although the lanthanides neodymium(III), samarium(III), and ytterbium(III) 
are all heavier than cerium(III), the ionic size is smaller and all have been observed to bind to 
transferrin in previous work (Du et al., 2002; Harris, 1986). 
 
Figure 3.3: UV-Vis absorbance spectra of the incremental additions of 0.25 equivalents Yb3+ to a 
buffer solution of 11.5 µM Tf up to a 4:1 molar ratio of ytterbium: transferrin. The other 
equivalents are omitted for clarity. 
 
Ytterbium(III) was the first lanthanide compared to cerium(III), and achieving a binding 
ratio of 1.75:1 molar ratio of ytterbium: transferrin. The spectra in Figure 3.3 shows that after 
addition of a 3:1 molar ratio of ytterbium: transferrin, the peaks at ~240 and ~290 nm are barely 
increasing. This indicates that the metal is no longer binding to transferrin even as more is added. 
It is possible that the kinetics of ytterbium(III)-transferrin binding are slow and the ytterbium did 
not finish binding to transferrin before the experiment was completed. The need to add excess 
ytterbium to the solutions may indicate that the ytterbium-transferrin complex is weaker than the 
iron complexes. 























To understand if the complexes of transferrin with larger lanthanides, such as cerium(III), 
were even weaker than the ytterbium-transferrin complexes, the binding of samarium and 
neodymium to transferrin were studied next. Note that the spectra in Figures 3.4 and 3.5 have 
different trends than in Figure 3.3. The reason is that the spectra in Figures 3.4 and 3.5 are 
difference spectra where the reference cuvette and the sample cuvette initially contained the 
same concentration of metal-free transferrin. The spectrum for transferrin was first taken and 
then subtracted from the spectra for the molar increment increases to clarify the change in 
spectra as metal was added. To clarify the trends observed, the change in molar absorptivity (De) 
were plotted to indicate the level of metal binding to transferrin. Figure 3.6 has e at 241.5 nm vs. 
the ytterbium(III): transferrin molar ratio. Figures 3.7a and 3.7b has De at 248 m for 
samarium(III): transferrin and neodymium(III): transferrin molar ratios respectively. 
 
Figure 3.4: UV-Vis difference spectra of the incremental additions of 0.25 equivalents Sm3+ to a 
buffer solution of 11.5 µM Tf up to a 3:1 molar ratio of samarium: transferrin. The other 
equivalents are omitted for clarity. 

























Figure 3.5: UV-Vis difference spectra of the incremental additions of 0.25 equivalents Nd3+ to a 
buffer solution of 11.5 µM Tf up to a 4:1 molar ratio of neodymium: transferrin. The other 


















































Figure 3.7: a) Dependence of De at 248 nm vs. molar ratio of samarium(III): transferrin using 
Figure 3.4 (left) and b) neodymium(III): transferrin using Figure 3.5 (right). 
 
Figure 3.6 shows ytterbium binding to transferrin. The optical absorption increases 
steadily up to a 1:1 molar ratio of ytterbium(III): transferrin and then tapers off. This indicates 
that the first equivalent of ytterbium binds to transferrin well but the second equivalent has 
weaker binding. Figure 3.7 shows that neither samarium nor neodymium bind to transferrin as 
strong as ytterbium. Also, that the second equivalent has only slightly weaker metal-binding than 
the first equivalent of metal. Consequently, the metals keep binding as more equivalents of 
lanthanide(III): transferrin are added and a substantial excess of metal over the two equivalents 
are required to saturate the active metal binding sites of transferrin. 
Since the difficulty for the trivalent lanthanides to bind to transferrin seems to increase as 
the ionic size gets larger, then the binding conditions for transferrin to bind to cerium(III), which 
is larger than either samarium or neodymium, would need to be slightly adjusted. Recall from 
earlier that transferrin and lactoferrin have different binding strengths for the same metal but low 
pH favors metal release from both proteins. If cerium(III) is unable to strongly bind to transferrin 
at pH 7.5, then increasing the pH should help the binding process. 

































Figure 3.8: UV-Vis absorbance spectra of the incremental additions of 0.5 equivalents Ce3+ to a 
buffer solution with ambient carbonate at pH 8 of 8 µM Tf up to a 4:1 molar ratio of cerium: 
transferrin. The other equivalents are omitted for clarity. 
 
Figures 3.2 and 3.8 represent the impact that the pH of the solution has on the cerium(III) 
binding to the protein. Although the pH is only 0.5 pH unit higher for Figure 3.6, significantly 
more cerium binding is observed. Unfortunately, higher pH increases the chance of cerium 
oxidation and precipitation prior to transferrin binding. After confirming that cerium did bind to 
the transferrin to form at least cerium(III)-transferrin but ideally (Ce3+)2Tf, the next phase is to 
oxidize the cerium(III) to cerium(IV). 
3.3.2  Cerium(IV)-Transferrin Complexes  
When cerium(III) is bound at the active metal binding site in transferrin, it should oxidize 
to cerium(IV) at the oxidation potentials normally encountered in aqueous solution. A simple but 
non-conclusive method to determine that the cerium oxidized in the transferrin is by the color of 
the solution. Cerium(III) metal in solution and (Ce3+)2Tf are both colorless. Cerium(IV) 




















compounds have been noted to make either a red or yellow colored solution (Medalia and Byrne, 
1951). Cerium(IV) in transferrin generally makes a red-brown solution (Smith et al., 1994). The 
synergistic anion can also slightly affect the color. (Ce4+)2Tf_NTA and carbonate as synergistic 
anions is generally a reddish solution as shown in Figure 3.9a. However, a lemon colored 
solution was reported with (Ce4+)2ALf (Swarts et al., 2000). ALf is Aspergillus awamori-derived 
recombinant human lactoferrin. 
                 
a) One carbonate and one NTA            b) Carbonate and no NTA  
Figure 3.9: Color differences with different synergistic anions to make Ce4+Tf. Although 
it is important to point out that the concentration of the transferrin will make the Ce4+Tf 
complex considerable darker as will be seen in Figure 3.15.  
 
Cerium(III)-transferrin with ambient carbonate in a HEPES and TRIS buffer at pH 7.5 
and 8.0 ± 0.1, respectively, was oxidized using H2O2, according to the procedure using cerium 
and lactoferrin (Smith et al., 1994). Treatment with H2O2 produced the lemon color in Figure 
3.10. The solution was warmed to ~30 °C and constantly stirred for faster oxidation. The 
yellowish solution was unexpected but since it is could be a form of Ce4+Tf, the metal-protein 
complex was later analyzed using SAXS. 
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Figure 3.10: ~8.5 µM of transferrin with 4:1 of cerium: transferrin at pH 8 with 2 µL of 30% 
hydrogen peroxide 
 
 However, further investigation suggest that H2O2 did not aid in the rapid oxidization of 
the cerium(III) in transferrin. The reason for this is that there is not a corresponding spectrum 
change that would indicate that the metal was oxidized while in the active metal binding site. 
Figure 3.11 shows one of the iterations of adding the H2O2 soon after the metal was added to the 
protein solution.  
 
Figure 3.11: UV-Vis spectrum analyzing cerium being oxidized using 30% hydrogen peroxide at 
pH 7.5. The solution contains 4:1molar ratio of cerium: transferrin (bottom spectra) with ~8.5 
µM transferrin. The subsequent increases have 0.5 and 1 µL H2O2 in solution. 














Note that even though the solution turned a yellowish color, as shown in Figure 3.10, 
there is no corresponding peak for the oxidized metal-protein complex that would represent the 
ligand to metal charge-transfer between the phenolate groups of transferrin and the cerium(IV) 
ions. It appears that cerium bound in transferrin’s lobes is inaccessible to the hydrogen peroxide 
when using near stoichiometric amounts. This suggests that either the cerium oxidized in 
solution, unbound to transferrin, or the yellow color arose from oxidation of the transferrin itself.  
Using ambient O2 to try and oxidize the cerium(III), a color change was not observed for 
pH 7.5 so pH 8.0 was used instead. The protein concentration was also increased to ~40 µM to 
improve visual confirmation of the color change. Two solutions were made that contained 
different concentrations of carbonate, ambient and 5 mM. As mentioned earlier, the 5mM 
carbonate buffer was made by degassing the buffer solution to remove the ambient carbonate and 
then sodium bicarbonate was added to the solution. The color change was noticed after a few 
hours the cerium was added to the solution. Figure 3.12 shows the spectra taken over the course 
of a week. The spectra do show a ligand to metal charge transfer band, similar to that observed 
for (Ce4+)2Tf_NTA in Figure 3.9a, suggesting that cerium(III) is being oxidized to cerium(IV) 
while bound to transferrin. 
        
a) Only ambient carbonate    b) 5mM carbonate  



























Figure 3.12 also shows that the ~435 nm peak is increasing at different rates, i.e. the 
oxidation of Ce3+Tf to Ce4+Tf is slower in Figure 3.12a than in Figure 3.12b. Even though the 
ambient levels of carbonate in solution should be enough to help cerium(III) bind to transferrin, 
the process is slow and takes almost a week before significant binding in the lobes is seen. The 
solution containing 5 mM carbonate forms Ce4+Tf within a few days. The molar extinction 
coefficients 1.03E5 M-1cm-1 and 4150 M-1cm-1 at the peaks 280 nm and 435 nm, respectively, can 
be used to determine the ratio of metal binding to the protein (Swarts et al., 2000; Bali and 
Harris, 1990).  Figure 3.13 shows two solutions with different concentrations of Ce4+Tf, that 
were analyzed three weeks after the cerium(III) was added to the solution.  While Figure 3.13b 
indicates oxidation of cerium in transferrin, using UV-Vis analysis by referencing the peak at 
280 nm it was found that ~1.5:1 molar ratio of cerium: transferrin bound and not the desired 2:1 
molar ratio cerium: transferrin. 
   
a)  Showing ~280 and ~435 nm peak       b) Focus on ~435 nm peak  
Figure 3.13: UV-Vis spectrum analyzing two concurrently formed solutions with 2:1 cerium: 
transferrin. 28 µM transferrin (purple, top spectra) and 14 µM transferrin (black, bottom spectra). 
 

























It is interesting that even though full metal binding may not have been achieved, Figure 
3.13 indicates that the solution contains both (Ce4+)1Tf and (Ce
4+)2Tf. This led to further 
experimentation to try and determine which lobe cerium(III) prefers.  
3.3.3  FeNCeCTf and FeCCeNTf Complexes 
 Having a ~1.5:1 molar ratio of cerium: transferrin raises the question that if lobe loading 
is occurring completely in one lobe, which lobe does the cerium(III) prefer or does cerium(III) 
have an equal preference for either lobe. This can be answered by making mix-metal complexes. 
FeNCeCTf and FeCCeNTf complexes were made using the procedure in 2.4.5. Figures 3.14a and 
Figure 3.14b show the spectra for cerium being added in the N and C-lobe respectively after the 
iron has bound in only the C and N-lobe respectively.  
 
       a)  FeCCeNTf               b) FeNCeCTf  
Figure 3.14: UV-Vis spectrum of 27 µM transferrin with iron in the C-lobe (a) and N-lobe (b). 
Filled black squares and red circles contained transferrin with iron. Empty black squares and red 
circles were loaded with 2:1 and 3:1of cerium: transferrin, respectively. For clarity-(1) and (2) 
denotes the sample number for their respective experiment. 
 
A week after the cerium(III) was added to the solution, the cerium(IV) was stripped using 
the strip solution procedure in Section 2.2.2. The pH of the solution was dropped to pH 4.5 but 

































the solution was still red-yellowish, albeit a lighter shade than before the strip solution was 
added. Under these conditions, the iron slowly releases slower than the cerium resulting in the 
lighter shade of red-yellow. By using the Arsenazo III assay procedure it was determined that a 
19.3:27 molar ratio of CeN: transferrin and a 19.1:27 molar ratio of CeC: transferrin concentration 
was present in their respective solutions. 
3.4  Carbonate Binding Studied Using 
13
C NMR. 
 Since lobe loading is approximately equivalent in both lobes then it is most likely that 
there are multiple carbonates being used instead of one as a synergistic anion(s). Recall that this 
is key for determining if the hypothesis can be tested. The assumption is that if only one 
carbonate bound to cerium(III), it would allow the N-lobe to close but having two carbonates 
may not allow the N-lobe to close. A method for tracking the carbonate in either the N or C-lobe 
is by using 13C NMR on 13C-labeled carbonate. A fortunate coincidence of using 13C NMR is that 
cerium(IV) does not have unpaired electrons, a test that could not have been done with 
plutonium(IV). Although, for the NMR experiment at least 1 mM transferrin, shown in Figure 




Figure 3.15: ~1 mM transferrin with 2:1 cerium: transferrin and carbonate. Note the darker color 
because of the higher concentration as compared to the transferrin in Figure 3.9. 
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Figure 3.16 shows the four main peaks of protein at 172-175 ppm, N-lobe binding at 
166.59 ppm, C-lobe binding at 166.6 ppm, and free carbonate at 160.5 ppm. The integration for 
the N and C-lobes are 20.94m and 57.72m respectively, with a 1:2.75 ratio of C-lobe: N-lobe. 
The N-lobe binding peak is approximately more than twice that of the C-lobe binding peak, 
which indicates that cerium is using two carbonates to bind in the N-lobe.  
 
Figure 3.16: 13C NMR spectra for Ce4+Tf in the presence of 5 mM carbonate in the carbonyl 
region. 
 
3.5  Verification of Lobe Conformation  
While the cerium-transferrin section demonstrates that Ce4+Tf complexes can be made in 







this confirms the correct conformation (complete closure of the C and N-lobe) of the complex, 
(Ce4+)2Tf. Over the course of this section, experiments were done with differing carbonate and 
protein concentrations, at pH 7.5 and 8.0, and under different oxidation methods. Since cerium is 
a being used as a surrogate for plutonium, the (Ce4+)2Tf should effectively represent the lobe 
conformation of (Pu4+)2Tf. The metal-protein complexes were analyzed using small angle x-ray 
scattering (SAXS). SAXS was also used for past plutonium and transferrin experiments to 
confirm the degree of lobe closure (Jensen et al., 2011). SAXS is a method that is sensitive to the 
shape and size of a protein using the deflection of X-rays as they impact the sample at minuscule 
angles, ~0.10. At low protein concentrations (50 µM) the pattern of deflection is determined by 
the shape of the particles deflecting the x-rays. The data obtained by SAXS can be used to show 
the overall conformation of the protein in three main categories: open, mixed (either C-lobe or 
N-lobe are open), and closed. This can be done by graphing the momentum space and pair-
distance distribution function, P(r) in real space and by modeling a low resolution molecular 
structure of the metal-protein complexes. 
3.5.1  Scattering of Cerium-Transferrin Complexes 
The background subtracted SAXS data are shown in Figure 3.17. By plotting the 
momentum space of the scattering vector as shown in Figure 3.17 one can compare some of the 
structural characteristic of all the proteins. Fully closed (Fe3+)2Tf has a scattering curve that is 
marked by a steep drop at Q=0.15 Å-1 and there is a noticeable concavity at 0.35 Å-1. Fully open 
apotransferrin has a gentle drop from 0.04 and 0.2 Å-1 and no concavity. (Ce4+)2Tf_NTA and 
Ce4+Tf_Carbonate follow the same trend as each other, with a blend of the apotransferrin and 
(Fe3+)2Tf. The curve is neither gentle nor steep but a moderate concavity at 0.32 Å
-1. 
Ce4+Tf_H2O2 has an even gentler curve than the apotransferrin but above 0.15 Å
-1 there is too 
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much noise to discern any more useful information from the metal-protein conformation. The 
lack of a level grade from 0.017-0.04 Å-1 for all of the proteins except (Fe3+)2Tf indicates some 
aggregation with apotransferrin and all the cerium-containing proteins. The aggregation is 
particularly pronounced for Ce4+Tf_H2O2.  
 
 
Figure 3.17: Graph of the momentum space SAXS curves for the proteins studied 
 
3.5.2 P(r)-distribution of Cerium-Transferrin Complexes 
Plotting the electron pair distance distribution in real space and normalizing the data, the 
protein structures that would have open or mixed lobes can be compared against the one with 
closed lobes. The peak in the graph corresponds to the widthwise distance of the bridge of the 
protein while the tail of the curve after the peak corresponds to the lengthwise distance of the 
whole protein. Recall from Figure 1.5 that the bridge would be the connection between the two 
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lobes. A narrow peak and a steep curve would indicate that the protein is closed and compact and 
vice versa.  Figure 3.18a compares (Fe3+)2Tf, apotransferrin, and Ce
4+Tf_H2O2. (Fe
3+)2Tf has a 
semi-steep descent after a narrow peak at 30 Å. Apotransferrin and Ce4+Tf_H2O2 have a broad 
peak from ~38 to 45 Å followed by gradual descent. Figure 3.18b shows (Ce4+)2Tf_NTA and 
Ce4+Tf_ Carbonate following the (Fe3+)2Tf curve then they diverge at ~38 Å and have a broad 
peak like apotransferrin but at 50 Å they follow within the (Fe3+)2Tf curve. The conformations of 
(Ce4+)2Tf_NTA and Ce
4+Tf_Carbonate are similar if not the same and different than either 
(Fe3+)2Tf or apotransferrin. 
  
 
  a)  Comparison of closed and open lobes         b) Comparison of closed and mixed lobes  
Figure 3.18: Normalized pair-distance distribution functions of (Fe3+)2Tf (red square) as a 
reference in both figures. Figure (a) compares Ce4+Tf_H2O2 (purple star) and apotransferrin (gray 
upside-down triangle). Figure (b) compares Ce4+Tf_ Carbonate (ochre triangle) and 
(Ce4+)2Tf_NTA (blue circle).  
 
3.5.3  Cerium-Transferrin Complexes Shape Reconstruction 
The data obtained by SAXS can be used to visually show the overall conformation of the 
protein in three main categories: open, mixed (either C-lobe or N-lobe are open), and closed with 
low resolution shape reconstruction. Solutions of apotransferrin and the (Fe3+)2Tf complex were 
made to provide a standard and comparison for the Ce4+Tf complexes. Apotransferrin has no 
































metal bound to the transferrin so both lobes should be completely open. (Fe3+)2Tf has an iron and 
carbonate in both lobes, as shown in Figure 1.5, so that both lobes should be completely closed.  
 Table 3.1 summarizes important values calculated as part of the shape reconstruction of 
the metal-protein complexes. As mentioned earlier, multiple Dmax values were used to determine 
the best estimate for the maximum dimension for the protein. The radius of gyration (Rg) has 
generally been used as a quantitative value to describe the overall size of the protein structures. 
The number of dummy atom models (DAMS) is the number of iterations used to make a single 
unique fit and the maximum number of unique fits is 15. 
 

















Apotransferrin 2 105 34.65 3323 12 1.006 
Apotransferrin 0.5 105 35.11 1406 15 0.1302 
(Fe3+)2Tf 5 97 30.06 2263 15 0.05941 
(Fe3+)2Tf 5 100 30.08 2962 14 0.03521 
Ce4+Tf_Carbonate (1) 6 110 35.68 1703 15 1.68 
Ce4+Tf_Carbonate (1) 6 100 32.85 1148 15 2.367 
Ce4+Tf_Carbonate (2) 6 100 33.36 5000 15 1.195 
Ce4+Tf_H2O2 10 95 34.09 5000 15 7.311 
Ce4+Tf_H2O2 0.5 115 39.25 1614 15 0.2736 
(Ce4+)2Tf_NTA 10 105 32.62 1850 15 1.2 
(Ce4+)2Tf_NTA 5 109 33.99 595 15 1.02 
 
Figure 3.19 shows a completely closed (Fe3+)2Tf complex overlaid by the low resolution 
structure of apotransferrin. Note that the (Fe3+)2Tf is compact, indicating that both lobes are 
closed, while the apotransferrin is stretched out, which indicates that the lobes are open.  
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Figure 3.19: Comparison of Apotransferrin (gray wireframe) and (Fe3+)2Tf (red wireframe). The 
arrows refer to the open lobes of the gray wireframe. 
 
The N-lobe in (Ce4+)2Tf_NTA has previously been observed to remain open. Having 
more than one synergistic anion, NTA and carbonate, to bind in the N-lobe is the suspected 
reason for the N-lobe remaining open. Therefore, along with the apotransferrin and (Fe3+)2Tf, the 
(Ce4+)2Tf_NTA was used as a reference for transferrin that has one lobe (C-lobe) closed and one 
lobe (N-lobe) open. Recall that an open lobe refers to a lobe not being fully closed, however an 
open lobe may still have a metal and a synergistic anion bound at the active metal site. Figure 




     
 
Figure 3.20: Comparison of (Ce4+)2Tf_NTA (blue wireframe) and (Fe
3+)2Tf (red wireframe). The 
arrow refers to the open lobe of the blue wireframe.  
 
As displayed in Figures 3.9 and 3.10, the Ce4+Tf_H2O2 showed neither the characteristic 
visual color change nor the peak increase in the spectrum. It was thought that it was still possible 
to have at least partial lobe closure if not full lobe closure. However, as seen in Figure 3.21, the 
metal-protein complex is distorted.  
     
 
Figure 3.21: Comparison of Ce4+Tf_H2O2 (purple wireframe) and (Fe




Figure 3.22 compares cerium(III)-transferrin made using 5 mM carbonate and oxidized to 
cerium(IV) using ambient O2 with (Fe
3+)2Tf. The shape conformation indicates that one of the 
lobes remained open. 
  




Figure 3.22: Comparison of Ce4+Tf_Carbonate (ochre wireframe) and (Fe
3+)2Tf (red wireframe). 
The arrow refers to the open lobe of the ochre wireframe. 
 
Since Ce4+Tf_Carbonate in Figure 3.22 is the shape conformation of particular interest, 
VMD was used to determine the length of the open lobe. It was necessary to use the dummy 
atom model to determine the width of the open lobe instead of the surface wireframe. Note that 
the spheres in Figure 3.23b do not correspond to the location of atoms but represent the 
framework used to generate the wireframe surface in Figure 3.23a. The lobe width, 58 ± 3 Å, 




      
         a)  Wireframe             b) Sphere Model 
Figure 3.23: Comparison of the Ce4+Tf_ Carbonate surface wireframe representation with the 
average ATSAS dummy atom model derived directly from the scattering data.  
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By using cerium for experimentation, a process was developed to make Ce4+Tf 
complexes that should accurately represent Pu4+Tf complexes. Recall that cerium was used as a 
surrogate for plutonium to develop the chemistry that could test the hypothesis that the N-lobe of 
transferrin would close in the presence of one plutonium and one carbonate, which could then be 
separated using the transferrin receptor protein. The separational process could then be used to 
develop an approach to make transferrins with the correct closed conformation by containing 
only one cerium and one carbonate in the N-lobe. Although the cerium experiments were 
intended to be a prelude to plutonium experiments, extensive analysis showed that this was 
unnecessary as the desired transferrin complex could not be created using cerium.  
It was thought that cerium(III)-transferrin would behave similar to cerium(III)-lactoferrin. 
However, other metal(III)-transferrin complex studies indicated that, depending on the metal, 
ambient or excess carbonate is optimal for metal binding. Ytterbium(III) is the second smallest 
lanthanide, has the highest charge density of the trivalent cations tested and should be the easiest 
to bind. While it was shown that ytterbium can bind using only ambient carbonate, it is able to 
bind to both lobes using 5 mM carbonate (Du et al., 2002). On the other hand, it was reported 
that excess carbonate could reduce the degree of complexation of transferrin with neodymium 
(Harris, 1986). The titration curves in Figures 3.6 and 3.7 appear to correlate the previous 
findings for ytterbium, samarium, and neodymium from those works.  
The conformation of transferrin bound to the lanthanides ytterbium, samarium and 
neodymium was not tested with SAXS and these complexes cannot be examined by 13C NMR 
because these ions are paramagnetic. Nevertheless, the binding behavior of those metal-protein 
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complexes worked as anticipated and had greater metal binding than cerium(III). Figure 3.7 
indicates that several molar equivalents of cerium(III) to transferrin would need to be added to 
the solution to encourage binding. Cerium(III) is the second largest of the lanthanides and 
therefore expected to be one of the hardest to load because as the lanthanide gets larger the 
binding to transferrin weakens. Similar behavior is expected for plutonium(III) as it is similar in 
size to cerium(III). Both the lanthanide and initial cerium experiments did show that the pH and 
carbonate concentration for the buffer had to be adjusted to maximize cerium(III)-transferrin 
binding.  
Even though the experiments with cerium(III)-lactoferrin and lanthanide (Yb, Sm, Nd)-
transferrin were done at pH 7.5 with ambient carbonate, only the 1:1 molar ratio of cerium(III): 
transferrin complex formed. The pH mediated release of cerium from lactoferrin showed that 
cerium starts to release from lactoferrin once the pH drops below 7.5 (Smith et al., 1994). Recall 
that lactoferrin binds to metals stronger than transferrin, if pH 7.5 represents the low end for 
lactoferrin binding to two cerium metals then transferrin requires a higher pH to bind to two 
cerium(III) ions as suggested by the spectra in Figure 3.8. This work showed that by increasing 
the pH to 8.0 also increased cerium(III) binding to transferrin, an important factor to consider 
when making cerium(III)-transferrin complexes (along with other metal-transferrin complexes). 
Starting with cerium(III) and plutonium(III), with carbonate instead of NTA, allows the 
metal to remain soluble until it binds to transferrin. However, once the metal binds in the metal 
binding sites, it needs to be oxidized to form stable cerium(IV)-transferrin or plutonium(IV)-
transferrin complexes. There are two main methods to oxidize (Ce3+)2Tf. Cerium(III) and 
plutonium(III) can simply be oxidized in the presence of atmospheric O2, however as hinted at in 
Figures 3.12 and 3.13, this process can take 2-3 weeks. An alternative approach for oxidizing 
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cerium(III)-transferrin was explored using H2O2 to see if the oxidizing process could be done in 
several seconds instead of several weeks.  
Depending on the system, the H2O2 can either instantly oxidize cerium(III) or reduce 
cerium(IV) (Yu et al., 2005). Based on previous cerium(IV)-lactoferrin experiments it was 
expected that the cerium(III) would be oxidized by H2O2 in transferrin (Smith et al., 1994). 
However, the H2O2 treatment did not work as expected with transferrin. While it seemed that the 
hydrogen peroxide oxidized the cerium(III), it appears unbound cerium(III) in solution was 
oxidized and not the cerium(III) bound in a closed lobe since the yellow color of the solution did 
not match the color of the Ce4+Tf complexes that were made with NTA and washed with excess 
carbonate. As noted earlier, it is likely that the hydrogen peroxide reacted directly with the 
transferrin and could not react with the cerium(III) in the lobes. In addition, SAXS showed that 
H2O2 treatment resulted in significant aggregation of the transferrin. Therefore, using H2O2 for 
oxidizing cerium or plutonium in transferrin is not recommended. 
It has been shown that while cerium(III) can bind to transferrin with and without 
carbonate at pH 8 in Figure 3.8, the cerium does not oxidize over a reasonable amount of time by 
the action of dissolved O2 unless excess carbonate, at least 5 mM, is present in solution. Even 
with the extra carbonate, the cerium still slowly oxidizes within the metal-binding sites, taking at 
least a fortnight with exposure to atmospheric O2. Since transferrin bound to cerium(III) is 
oxidized by O2, an alternative for faster oxidization of the trivalent metal would be to bubble 
concentrated O2 through the solution or use similar means to increase the partial pressure of O2 
in the solution once the metal is bound to transferrin. However, there are two difficulties with 
this approach. One difficulty is that it would be challenging to know when all the cerium(III) is 
oxidized and the other difficulty is bubbling with high purity O2 would displace the dissolved 
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carbon dioxide in the solution, effectively reducing the bicarbonate/carbonate concentration. 
Although this process, using ambient O2, can make Ce
4+Tf complexes, the N-lobe still does not 
close, as visually shown earlier in Figure 3.22.  
The loading of cerium(III) into the two individual lobes was tested by forming FeNCeCTf 
and FeCCeNTf complexes. While neither complex had as much cerium(IV) as anticipated, ~70% 
of the theoretical maximum, these experiments demonstrated that the cerium bound almost 
equally to both lobes. It is possible that a time longer than a fortnight is required to allow the 
cerium(III) to fully bind to the transferrin.  
After studying the cerium binding to transferrin, 13C NMR was used to track carbonate 
binding in the C or N-lobe to understand if one Ce-CO3 complex was formed in each lobe. 
Figure 4.1 shows the 13C NMR spectra of another member of the transferrin family, 
ovotransferrin (OTf). Similar NMR spectra are observed for transferrin and lactoferrin. 
 
Figure 4.1: 13C NMR spectra in the carbonyl region of 1.13 mM blank OTf with free 13C in 
solution. “Reprinted with permission from Aramini, James M., and Hans J. Vogel. “Aluminum-
27 and Carbon-13 NMR Studies of aluminum(3+) Binding to Ovotransferrin and Its Half-
Molecules.” Journal of the American Chemical Society 115, no. 1 (January 1, 1993): 245–52. 
doi:10.1021/ja00054a035. Copyright 1993 American Chemical Society.” 
 
Figure 4.2 shows the 13C NMR of 1.13 mM apo-OTf in the presence of 20 mM 
Na2





resonance at ~161 ppm corresponds to the free bicarbonate in solution (Bertini et al., 1986). 
When labeled carbonate binds to transferrins containing diamagnetic metal ions, such as 
cerium(IV), new peaks appear in the 13C NMR that represent carbonate bound to the metal in 
either the C or N-lobe; an example is shown in Figure 4.2. The peaks at 165.3 and 165.7 ppm 
represent aluminum(III)-carbonate bound in the C-lobe and the N-lobe respectively. While the 
exact chemical shift values vary from metal to metal, carbonate bound in the C-lobe has always 
been observed to occur at a lower chemical shift than carbonate bound in the N-lobe. 
 
 
Figure 4.2: 13C NMR spectra of OTf with Al3+ and carbonate in the carbonyl region: (a) 1.13 mM 
OTf, 20 mM Na2
13CO3, 2:1 of Al: OTf (b) 1.25 mM OTf, 10 mM Na2
13CO3, 1:1 of Al: OTf (c) 
0.19 mM OTf, 5 mM Na2
13CO3, 1:1 of Al: OTf. “Reprinted with permission from Aramini, 
James M., and Hans J. Vogel. “Aluminum-27 and Carbon-13 NMR Studies of aluminum(3+) 
Binding to Ovotransferrin and Its Half-Molecules.” Journal of the American Chemical Society 
115, no. 1 (January 1, 1993): 245–52. doi:10.1021/ja00054a035. Copyright 1993 American 
Chemical Society.” 
 
165.3 ppm 165.7 ppm 
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By making (Ce4+)2Tf complexes from 
13C labeled sodium carbonate with cerium(III), the 
NMR spectra in Figure 3.16 provides a critical piece of the puzzle by showing what was 
occurring with cerium(IV)-carbonate complex within the N-lobe. While it was assumed that only 
one Ce-CO3 complex was in each lobe, the NMR experiment showed that the N-lobe contains 
two carbonates per cerium(IV), while the C-lobe has one carbonate. Instead of Ce-CO3 in the N-
lobe, there is a Ce-(CO3)2 complex in the N-lobe. This is problematic because there seems to be a 
size restriction at the metal binding site of no more than 7 Å to achieve a closed N-lobe and the 
estimated size needed to accommodate carbonate is 4.6 Å (Schlabach and Bates, 1974). It would 
be safe to assume that even if two carbonates do not necessarily need 9.2 Å at the metal binding 
site, two carbonates would exceed the size restriction for a closed N-lobe. 
Having two carbonates bind to the metal ion suggest that the lobe would be forced to stay 
open. This would also explain why the cerium did not readily bind to the transferrin with only 
ambient carbonate in the solution, the cerium(III) needs access to excess carbonate in order to 
bind to the N-lobe. Having excess carbonate encouraged stronger binding and faster oxidation of 
cerium(III) while bound to transferrin. However, it was not possible to make Ce-CO3 complexes 
in the N-lobe. Even though a Ce-CO3 complex was not made in transferrin’s N-lobe, the 
conformation was still checked and compared because cerium(IV)-lactoferrin has closed lobes as 
shown in Figure 4.3. 
Comparison of the lobe closure was done using SAXS. The concentration of transferrin 
will affect the scattering intensity in multiple ways. Concentrations more than approximately 10 
mg/mL of transferrin can cause aggregation, which will make the Dmax appear larger than is 
physically true and distorts the reconstructed protein shape. However, at low concentrations, less 
than approximately 1 mg/mL of transferrin, the scattering at high Q values will be too weak for 
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reliable shape reconstruction at shorter scattering distances, which can mask the open nature of 
transferrin’s lobes. Therefore, a series of different transferrin concentrations were studied as 
shown in section 3.5.2 to determine the best representation for each set. 
 
 
Figure 4.3: Lactoferrin protein with both lobes closed around the cerium (ochre) and carbonate 
(oxygen-blue, carbon-cyan).  Image constructed using VMD from PDB ID: 1FCK (Baker et al., 
2000). 
 
The first part of analyzing SAXS data was to compare the scattering of different proteins 
as a function of the scattered angles (I(Q) vs. Q) which can illuminate particular differences 
between the open, mixed, and close conformations.  The momentum space graph in Figure 3.17, 
shows the main differences between the metal-protein complexes. (Fe3+)2Tf has a steep drop and 
a noticeable concavity afterwards, which are two characteristics of lobe closure. Apotransferrin 
has a gentle drop and no concavity, which indicates that both lobes are open. The curves for 
(Ce4+)2Tf_NTA and Ce
4+Tf_Carbonate follow the same drop as apotransferrin but then have the 
concavity that is present for (Fe3+)2Tf, suggesting a mixed conformation. A follow-up step to 
looking at the momentum space is to examine the pair distance distribution function, P(r), in real 
space. 
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 As shown in Figure 4.4, the P(r) function can illustrate certain characteristics of proteins. 
P(r) specifically looks at the pair-distance of the scattering atoms in the protein, which also gives 
the Dmax, the maximum dimension of the protein. Even though Figure 4.4 represents a broad 
collection of proteins from the protein data bank, it demonstrates that specific pair distribution 
functions arise from each protein with a different shape. The P(r) function can also show the 
overall conformation of transferrin as the closed, mixed, and open conformations have distinct 
shapes. 
 
Figure 4.4: Pair-distance distribution function of a hundred proteins (Liu and Zwart, 2012). 
  
At shorter distances, the scattering is consistent with all three configurations for closed, 
mixed, and open. The farther apart atoms are in the protein, for example in an open lobe of 
transferrin, the broader the P(r) function will be compared to a protein with closed lobes. An 
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example of the latter is (Fe3+)2Tf which is shown as a narrow peak in the P(r), is the only one that 
shows that both lobes are closed. An opposite extreme is Ce4+Tf_H2O2 that has both a broader 
peak than the apotransferrin peak and a gentler drop, indicating that the transferrin in this sample 
has aggregated and been degraded, which was also seen in the Figure 3.17. (Ce4+)2Tf_NTA and 
Ce4+Tf_Carbonate have a broad peak like apotransferrin that indicates there is an open lobe but 
they diverge and follow the (Fe3+)2Tf curve, at the lowest and highest distances, which indicates 
that the other lobe is closed.  
 The final step in analyzing the SAXS data is low-resolution shape reconstructions as 
shown in Figures 3.19-3.22. Each of the conformations derived from the shape reconstruction 
confirm what was surmised in qualitative analysis of the momentum space and pair distribution 
data. (Fe3+)2Tf and apotransferrin represented open and closed lobes respectively. 
(Ce4+)2Tf_NTA and Ce
4+Tf_Carbonate are quite similar in structure with one open and one 
closed lobe.  
To ensure that the shape reconstruction of (Ce4+)2Tf_NTA and Ce
4+Tf_Carbonate are 
accurately reproducing the open N-lobe, and that the N-lobe is actually open in these proteins, 
the size (i.e. width) of the open N-lobe of the reconstructed Ce4+Tf_Carbonate structure was 
compared to an N-lobe containing iron-carbonate and with no metal in Figure 4.5. The sulfur 
atoms were mapped as reference points to help differentiate between the N and C-lobe of 
transferrin. The bulk of sulfur atoms in the left section of the figures indicate the eight disulfide 
bonds that are present in the N-lobe (Luck and Mason, 2015). The equivalent distance of the 
closed and open N-lobe in Figure 4.5 was shown to be 52 ± 2 Å and 60.5 ± 2 Å, respectively. 
The difference of the lobe in Figure 3.23 and the lobe in Figure 4.5b indicate that the N-lobe is 
essentially open and still has a way to be fully closed at 52 Å.  
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   a)  Closed N-lobe             b) Open N-lobe 
Figure 4.5: The estimated width for the N-lobe of transferrin with sulfur (yellow) and iron (red).  
(a) Closed N-lobe with image constructed using VMD from PDB ID: 1N84, (Adams et al., 
2003). (b) Open N-lobe with image constructed using VMD from PDB ID: 1BP5, (Jeffery et al., 
1998). 
 
Despite using an approach that produced closed cerium(IV)-lactoferrin with one 
carbonate in each lobe. Cerium(IV)-transferrin containing only one carbonate in the N-lobe was 
unable to be produced, which would have allowed testing of the original hypothesis with 
plutonium(III)-transferrin. However, even though the experiments could not test the original 
hypothesis, this work has contributed to understanding the behavior of transferrin and answers a 
different hypothesis. This alternative hypothesis is that the cerium(IV)-transferrin complexes 
cannot be made with one carbonate in the N-lobe. The experimental results from the 
spectroscopic analysis, cerium binding assays, and SAXS are all consistent with the conclusion 
found using 13C NMR. Even in 5 mM carbonate solutions without NTA present, two synergistic 
carbonate anions are present in the N-lobe, and the N-lobe was still open. Using the two different 
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carbonate concentrations also did not produce the desired cerium loading in transferrin, as 
cerium did not bind effectively to transferrin at ambient carbonate concentrations.  
This result is interesting because of a recent study of thorium(IV) and its binding to 
transferrin. In that study, complete binding of thorium(IV) to transferrin required two carbonates 
per bound thorium was reported (Le Du et al., 2012). In addition, complete binding of thorium 
was not achieved until the carbonate concentration in solution was at least 5 mM carbonate. 
Although thorium(IV) is slightly larger in ionic size than cerium(IV), these thorium observations 
imply that the findings with transferrin are a general limitation for tetravalent actinide or 
lanthanide cations. If the carbonate concentration is less than 5 mM then a one carbonate 
concentration is too low to get the metal ion (cerium, plutonium, or thorium) to bind to 
transferrin in the absence of another ligand that can keep the metal ion in near neutral solutions. 
The issue experienced with thorium might be the same reason cerium needs two carbonates to 
act as a synergistic anion in the N-lobe. However, using another member of the transferrin family 
or a different synergistic anion might allow cerium(III)/plutonium(III) binding and oxidation, 
thus allowing a closed lobe conformation for the N-lobe. 
Considering there seems to be an inherent limitation in transferrin binding of the 
actinides(IV), another member of the transferrin family might be a better choice for obtaining a 
fully closed conformation. Lactoferrin could be considered as an alternative to transferrin, and 
cerium(IV)-lactoferrin complexes that were made and tested gave results that agreed with the 
previously published studies, showing a binding of 2:1 molar ratio of cerium: lactoferrin. The 
difficulty with this approach is that the lactoferrin receptor proteins are not well understood like 
the transferrin receptor protein. This would make the goal of two-stage separation process with 
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plutonium more difficult than using transferrin since a lot of work with the lactoferrin receptor 
protein would be required. 
Although, no experiments in this work were conducted with plutonium and transferrin, 
the results from the cerium-transferrin complexes rendered experiments with (Pu4+)2Tf 
unnecessary. Nevertheless, this work has contributed in understanding cellular plutonium uptake 
by showing that plutonium should have two carbonates bound in the N-lobe at physiological 
carbonate concentrations of blood, which is ~25 mM. When there is sufficient carbonate present 
to promote effective binding of cerium to transferrin (~5 mM), two carbonates will bind in the 
N-lobe and the N-lobe will stay open. Similarly, if the carbonate concentration was low enough 
to allow a single carbonate attached to plutonium(III) to bind to transferrin, the total carbonate 
concentration would be too low for effective plutonium binding in the N-lobe. Finally, it should 
be noted that a plutonium separation process could still be based on transferrin if the containing 
metals caused both lobes of transferrin to close or if (Fe3+)NTf was used as the active protein 
before plutonium is added to the protein solution so that it can bind to the transferrin receptor 
protein.  
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Determining the most effective ways to recycle useful elements and to permanently 
dispose hazardous and impractical materials from used nuclear fuel is an ongoing process. 
Chemically based separations have been a mainstay for actinide separations since the 1940s 
however these processes can be improved. Biological systems have naturally developed a 
framework for managing and transporting metals which potentially can be used for synthetic 
metals, e.g. plutonium. While there are several elements that pose a health hazard and have no 
discernable physiological role, none of the primordial elements compare to the inherent toxicity 
of plutonium. Yet biological systems are able to recognize and, in a series of stages, transport 
plutonium. 
Since two carbonates bind the larger actinide(IV) and lanthanide(IV) cations in 
transferrin, as previously seen with thorium(IV) and now with cerium(IV). A possible direction 
would be to use a different synergistic anion that could produce a closed N-lobe. Such a 
synergistic anion would have to be smaller than NTA, bind at least as strong as carbonate, keep 
the trivalent metal in solution, and allow oxidation of the trivalent metal to the tetravalent 
oxidation state when bound to transferrin. One difficulty of working with plutonium in such a 
system is that plutonium(III) is easier to oxidize than cerium(III), so it could be difficult to 
keeping plutonium(III) in solution long enough for it to bind to transferrin, instead of precipitate 
as plutonium(IV). Using different synergistic anions may work to allow the lobe to fully close 
however this would require extensive work to optimize the system. Since the transferrins can 
bind to many metals and understanding how the lobes can be closed along with differing 
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synergistic anions may be able to lead to different conformations to allow for a selective 
separation. 
Lactoferrin, while not as versatile as serum transferrin, has stronger metal binding than 
transferrin. There are two issues with using lactoferrin. While minor, the first issue that could 
prove to be problematic is that apolactoferrin is not commercially available. While it is possible 
to strip out the iron from lactoferrin, it is difficult to remove all of the iron without damaging the 
protein. The probable iron contamination would skew results when determining the amount of 
bound and unbound f-element ions.  If it is possible to use apolactoferrin, this would be a 
worthwhile experiment to pursue. The active metal binding sites are structurally similar but full 
lobe closure could likely be obtained for lactoferrin. At least making the (Ce4+)2
 Lf complexes 
would be easier. The other issue is that separate binding tests of lactoferrin with the lactoferrin 
transferrin receptor protein would need to be done in order to develop a two-stage separation.  
Considering that the transferrins can bind to dozens of different metals including other 
actinides offers other possibilities for using transferrins to separate actinides other than just 
plutonium. The metal-binding versatility of the transferrins suggests different binding 
requirements for metals for both strong binding and a closed conformation of its metal-binding 
sites. Full understanding of how the actinides and specific synergistic anions affect lobe closure 
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